Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 40 entries
Sorted by: Best Match Show Resources per page
Pharmacological Transdifferentiation of Human Nasal Olfactory Stem Cells into Dopaminergic Neurons.

Stem cells international

Chabrat A, Lacassagne E, Billiras R, Landron S, Pontisso-Mahout A, Darville H, Dupront A, Coge F, Schenker E, Piwnica D, Nivet E, Féron F, Mannoury la Cour C.
PMID: 31236114
Stem Cells Int. 2019 May 19;2019:2945435. doi: 10.1155/2019/2945435. eCollection 2019.

The discovery of novel drugs for neurodegenerative diseases has been a real challenge over the last decades. The development of patient- and/or disease-specific

Cite
Chabrat A, Lacassagne E, Billiras R, et al. Pharmacological Transdifferentiation of Human Nasal Olfactory Stem Cells into Dopaminergic Neurons. Stem Cells Int. 2019;2019:2945435doi: 10.1155/2019/2945435.
Chabrat, A., Lacassagne, E., Billiras, R., Landron, S., Pontisso-Mahout, A., Darville, H., Dupront, A., Coge, F., Schenker, E., Piwnica, D., Nivet, E., Féron, F., & Mannoury la Cour, C. (2019). Pharmacological Transdifferentiation of Human Nasal Olfactory Stem Cells into Dopaminergic Neurons. Stem cells international, 20192945435. https://doi.org/10.1155/2019/2945435
Chabrat, Audrey, et al. "Pharmacological Transdifferentiation of Human Nasal Olfactory Stem Cells into Dopaminergic Neurons." Stem cells international vol. 2019 (2019): 2945435. doi: https://doi.org/10.1155/2019/2945435
Chabrat A, Lacassagne E, Billiras R, Landron S, Pontisso-Mahout A, Darville H, Dupront A, Coge F, Schenker E, Piwnica D, Nivet E, Féron F, Mannoury la Cour C. Pharmacological Transdifferentiation of Human Nasal Olfactory Stem Cells into Dopaminergic Neurons. Stem Cells Int. 2019 May 19;2019:2945435. doi: 10.1155/2019/2945435. eCollection 2019. PMID: 31236114; PMCID: PMC6545791.
Copy Download .nbib Format: NLM
When people living with dementia say 'no': Negotiating refusal in the acute hospital setting.

Social science & medicine (1982)

O'Brien R, Beeke S, Pilnick A, Goldberg SE, Harwood RH.
PMID: 32823045
Soc Sci Med. 2020 Oct;263:113188. doi: 10.1016/j.socscimed.2020.113188. Epub 2020 Jul 17.

A quarter of UK acute hospital beds are occupied by people living with dementia (PLWD). Concerns have been raised by both policy makers and carers about the quality of communication between hospital staff and PLWD. PLWD may experience communication...

Cite
O'Brien R, Beeke S, Pilnick A, et al. When people living with dementia say 'no': Negotiating refusal in the acute hospital setting. Soc Sci Med. 2020;263:113188doi: 10.1016/j.socscimed.2020.113188.
O'Brien, R., Beeke, S., Pilnick, A., Goldberg, S. E., & Harwood, R. H. (2020). When people living with dementia say 'no': Negotiating refusal in the acute hospital setting. Social science & medicine (1982), 263113188. https://doi.org/10.1016/j.socscimed.2020.113188
O'Brien, Rebecca, et al. "When people living with dementia say 'no': Negotiating refusal in the acute hospital setting." Social science & medicine (1982) vol. 263 (2020): 113188. doi: https://doi.org/10.1016/j.socscimed.2020.113188
O'Brien R, Beeke S, Pilnick A, Goldberg SE, Harwood RH. When people living with dementia say 'no': Negotiating refusal in the acute hospital setting. Soc Sci Med. 2020 Oct;263:113188. doi: 10.1016/j.socscimed.2020.113188. Epub 2020 Jul 17. PMID: 32823045.
Copy Download .nbib Format: NLM
SARS-Cov-2 pneumonia and concurrent myelodysplasia complicated by Pseudomonas aeruginosa over-infection.

Journal of virological methods

Pezzuto A, Tammaro A, Tonini G, Conforti G, Falangone F, Spuntarelli V, Teggi A, Pennica A.
PMID: 34896451
J Virol Methods. 2021 Dec 10;300:114419. doi: 10.1016/j.jviromet.2021.114419. Epub 2021 Dec 10.

The new virus called severe acute respiratory syndrome coronavirus 2 (SARSCov-2) causing Coronavirus disease 2019 (COVID-19) has spread quickly in several countries and it has become pandemic. Different types of clinical manifestations are attributed to this infection. Some mechanisms...

Cite
Pezzuto A, Tammaro A, Tonini G, et al. SARS-Cov-2 pneumonia and concurrent myelodysplasia complicated by Pseudomonas aeruginosa over-infection. J Virol Methods. 2021;300:114419doi: 10.1016/j.jviromet.2021.114419.
Pezzuto, A., Tammaro, A., Tonini, G., Conforti, G., Falangone, F., Spuntarelli, V., Teggi, A., & Pennica, A. (2021). SARS-Cov-2 pneumonia and concurrent myelodysplasia complicated by Pseudomonas aeruginosa over-infection. Journal of virological methods, 300114419. https://doi.org/10.1016/j.jviromet.2021.114419
Pezzuto, Aldo, et al. "SARS-Cov-2 pneumonia and concurrent myelodysplasia complicated by Pseudomonas aeruginosa over-infection." Journal of virological methods vol. 300 (2021): 114419. doi: https://doi.org/10.1016/j.jviromet.2021.114419
Pezzuto A, Tammaro A, Tonini G, Conforti G, Falangone F, Spuntarelli V, Teggi A, Pennica A. SARS-Cov-2 pneumonia and concurrent myelodysplasia complicated by Pseudomonas aeruginosa over-infection. J Virol Methods. 2021 Dec 10;300:114419. doi: 10.1016/j.jviromet.2021.114419. Epub 2021 Dec 10. PMID: 34896451; PMCID: PMC8660133.
Copy Download .nbib Format: NLM
Comparison of Computerized Prescription Support Systems in COVID-19 Patients: INTERCheck and Drug-PIN.

SN comprehensive clinical medicine

Martocchia A, Bruscia C, Conforti G, Falangone F, Marini V, Pennica A, Pezzuto A, March MR, Sentimentale A, Spuntarelli V, Tafaro L, Ricci A, Simmaco M, Sesti G, Preissner R, Martelletti P.
PMID: 34977463
SN Compr Clin Med. 2021;4(1):3. doi: 10.1007/s42399-021-01079-9. Epub 2021 Dec 27.

The coronavirus disease 19 (COVID-19) infection requires major efforts in healthcare systems, due to the high risk of mortality, particularly in subjects with significant comorbidity (≥ 2 pathologies) and polypharmacy (≥ 5 drugs). The treatment of COVID-19 needs a...

Cite
Martocchia A, Bruscia C, Conforti G, et al. Comparison of Computerized Prescription Support Systems in COVID-19 Patients: INTERCheck and Drug-PIN. SN Compr Clin Med. 2021;4(1):3doi: 10.1007/s42399-021-01079-9.
Martocchia, A., Bruscia, C., Conforti, G., Falangone, F., Marini, V., Pennica, A., Pezzuto, A., March, M. R., Sentimentale, A., Spuntarelli, V., Tafaro, L., Ricci, A., Simmaco, M., Sesti, G., Preissner, R., & Martelletti, P. (2021). Comparison of Computerized Prescription Support Systems in COVID-19 Patients: INTERCheck and Drug-PIN. SN comprehensive clinical medicine, 4(1), 3. https://doi.org/10.1007/s42399-021-01079-9
Martocchia, Antonio, et al. "Comparison of Computerized Prescription Support Systems in COVID-19 Patients: INTERCheck and Drug-PIN." SN comprehensive clinical medicine vol. 4,1 (2021): 3. doi: https://doi.org/10.1007/s42399-021-01079-9
Martocchia A, Bruscia C, Conforti G, Falangone F, Marini V, Pennica A, Pezzuto A, March MR, Sentimentale A, Spuntarelli V, Tafaro L, Ricci A, Simmaco M, Sesti G, Preissner R, Martelletti P. Comparison of Computerized Prescription Support Systems in COVID-19 Patients: INTERCheck and Drug-PIN. SN Compr Clin Med. 2021;4(1):3. doi: 10.1007/s42399-021-01079-9. Epub 2021 Dec 27. PMID: 34977463; PMCID: PMC8710931.
Copy Download .nbib Format: NLM
The role of vasopressin V1A and oxytocin OTR receptors in protective effects of arginine vasopressin against H.

Archives of physiology and biochemistry

Ghorbanzadeh V, Jafarpour A, Pirnia A, Pajouhi N, Khaksarian M, Veiskarami S, Nazari A.
PMID: 32141340
Arch Physiol Biochem. 2020 Mar 06;1-6. doi: 10.1080/13813455.2020.1729816. Epub 2020 Mar 06.

No abstract available.

Cite
Ghorbanzadeh V, Jafarpour A, Pirnia A, et al. The role of vasopressin V1A and oxytocin OTR receptors in protective effects of arginine vasopressin against H. Arch Physiol Biochem. 2020;1-6doi: 10.1080/13813455.2020.1729816.
Ghorbanzadeh, V., Jafarpour, A., Pirnia, A., Pajouhi, N., Khaksarian, M., Veiskarami, S., & Nazari, A. (2020). The role of vasopressin V1A and oxytocin OTR receptors in protective effects of arginine vasopressin against H. Archives of physiology and biochemistry, 1-6. https://doi.org/10.1080/13813455.2020.1729816
Ghorbanzadeh, Vajihe, et al. "The role of vasopressin V1A and oxytocin OTR receptors in protective effects of arginine vasopressin against H." Archives of physiology and biochemistry vol. (2020): 1-6. doi: https://doi.org/10.1080/13813455.2020.1729816
Ghorbanzadeh V, Jafarpour A, Pirnia A, Pajouhi N, Khaksarian M, Veiskarami S, Nazari A. The role of vasopressin V1A and oxytocin OTR receptors in protective effects of arginine vasopressin against H. Arch Physiol Biochem. 2020 Mar 06;1-6. doi: 10.1080/13813455.2020.1729816. Epub 2020 Mar 06. PMID: 32141340.
Copy Download .nbib Format: NLM
Topical Treatment of Rosacea with Ivermectin Inhibits Gene Expression of Cathelicidin Innate Immune Mediators, LL-37 and KLK5, in Reconstructed and Ex Vivo Skin Models.

Dermatology and therapy

Thibaut de Ménonville S, Rosignoli C, Soares E, Roquet M, Bertino B, Chappuis JP, Defoin-Platel/Chaussade C, Piwnica D.
PMID: 28243927
Dermatol Ther (Heidelb). 2017 Jun;7(2):213-225. doi: 10.1007/s13555-017-0176-3. Epub 2017 Feb 27.

INTRODUCTION: Numerous intrinsic and extrinsic factors have been associated with the pathophysiology of rosacea, including dysregulation of innate immunity. A high level of cathelicidin antimicrobial peptides (e.g., LL-37) has been shown in the facial skin of patients with rosacea....

Cite
Thibaut de Ménonville S, Rosignoli C, Soares E, et al. Topical Treatment of Rosacea with Ivermectin Inhibits Gene Expression of Cathelicidin Innate Immune Mediators, LL-37 and KLK5, in Reconstructed and Ex Vivo Skin Models. Dermatol Ther (Heidelb). 2017;7(2):213-225doi: 10.1007/s13555-017-0176-3.
Thibaut de Ménonville, S., Rosignoli, C., Soares, E., Roquet, M., Bertino, B., Chappuis, J. P., Defoin-Platel/Chaussade, C., & Piwnica, D. (2017). Topical Treatment of Rosacea with Ivermectin Inhibits Gene Expression of Cathelicidin Innate Immune Mediators, LL-37 and KLK5, in Reconstructed and Ex Vivo Skin Models. Dermatology and therapy, 7(2), 213-225. https://doi.org/10.1007/s13555-017-0176-3
Thibaut de Ménonville, Séverine, et al. "Topical Treatment of Rosacea with Ivermectin Inhibits Gene Expression of Cathelicidin Innate Immune Mediators, LL-37 and KLK5, in Reconstructed and Ex Vivo Skin Models." Dermatology and therapy vol. 7,2 (2017): 213-225. doi: https://doi.org/10.1007/s13555-017-0176-3
Thibaut de Ménonville S, Rosignoli C, Soares E, Roquet M, Bertino B, Chappuis JP, Defoin-Platel/Chaussade C, Piwnica D. Topical Treatment of Rosacea with Ivermectin Inhibits Gene Expression of Cathelicidin Innate Immune Mediators, LL-37 and KLK5, in Reconstructed and Ex Vivo Skin Models. Dermatol Ther (Heidelb). 2017 Jun;7(2):213-225. doi: 10.1007/s13555-017-0176-3. Epub 2017 Feb 27. PMID: 28243927; PMCID: PMC5453918.
Copy Download .nbib Format: NLM
Evaluation of co-cultured spermatogonial stem cells encapsulated in alginate hydrogel with Sertoli cells and their transplantation into azoospermic mice.

Zygote (Cambridge, England)

Veisi M, Mansouri K, Assadollahi V, Jalili C, Pirnia A, Salahshoor MR, Hoseinkhani Z, Gholami MR.
PMID: 34610855
Zygote. 2021 Oct 06;1-8. doi: 10.1017/S0967199421000733. Epub 2021 Oct 06.

An in vitro spermatogonial stem cell (SSC) culture can serve as an effective technique to study spermatogenesis and treatment for male infertility. In this research, we compared the effect of a three-dimensional alginate hydrogel with Sertoli cells in a...

Cite
Veisi M, Mansouri K, Assadollahi V, et al. Evaluation of co-cultured spermatogonial stem cells encapsulated in alginate hydrogel with Sertoli cells and their transplantation into azoospermic mice. Zygote. 2021;1-8doi: 10.1017/S0967199421000733.
Veisi, M., Mansouri, K., Assadollahi, V., Jalili, C., Pirnia, A., Salahshoor, M. R., Hoseinkhani, Z., & Gholami, M. R. (2021). Evaluation of co-cultured spermatogonial stem cells encapsulated in alginate hydrogel with Sertoli cells and their transplantation into azoospermic mice. Zygote (Cambridge, England), 1-8. https://doi.org/10.1017/S0967199421000733
Veisi, Mohammad, et al. "Evaluation of co-cultured spermatogonial stem cells encapsulated in alginate hydrogel with Sertoli cells and their transplantation into azoospermic mice." Zygote (Cambridge, England) vol. (2021): 1-8. doi: https://doi.org/10.1017/S0967199421000733
Veisi M, Mansouri K, Assadollahi V, Jalili C, Pirnia A, Salahshoor MR, Hoseinkhani Z, Gholami MR. Evaluation of co-cultured spermatogonial stem cells encapsulated in alginate hydrogel with Sertoli cells and their transplantation into azoospermic mice. Zygote. 2021 Oct 06;1-8. doi: 10.1017/S0967199421000733. Epub 2021 Oct 06. PMID: 34610855.
Copy Download .nbib Format: NLM
SARS-Cov-2 pneumonia and concurrent myelodysplasia complicated by pseudomonas aeruginosa over-infection.

Journal of virological methods

Pezzuto A, Tammaro A, Tonini G, Conforti G, Falangone F, Spuntarelli V, Teggi A, Pennica A.
PMID: 34896451
J Virol Methods. 2021 Dec 10;300:114419. doi: 10.1016/j.jviromet.2021.114419. Epub 2021 Dec 10.

The new virus called severe acute respiratory syndrome coronavirus 2 (SARSCov-2) causing Coronavirus disease 2019 (COVID-19) has spread quickly in several countries and it has become pandemic. Different types of clinical manifestations are attributed to this infection. Some mechanisms...

Cite
Pezzuto A, Tammaro A, Tonini G, et al. SARS-Cov-2 pneumonia and concurrent myelodysplasia complicated by pseudomonas aeruginosa over-infection. J Virol Methods. 2021;300:114419doi: 10.1016/j.jviromet.2021.114419.
Pezzuto, A., Tammaro, A., Tonini, G., Conforti, G., Falangone, F., Spuntarelli, V., Teggi, A., & Pennica, A. (2021). SARS-Cov-2 pneumonia and concurrent myelodysplasia complicated by pseudomonas aeruginosa over-infection. Journal of virological methods, 300114419. https://doi.org/10.1016/j.jviromet.2021.114419
Pezzuto, Aldo, et al. "SARS-Cov-2 pneumonia and concurrent myelodysplasia complicated by pseudomonas aeruginosa over-infection." Journal of virological methods vol. 300 (2021): 114419. doi: https://doi.org/10.1016/j.jviromet.2021.114419
Pezzuto A, Tammaro A, Tonini G, Conforti G, Falangone F, Spuntarelli V, Teggi A, Pennica A. SARS-Cov-2 pneumonia and concurrent myelodysplasia complicated by pseudomonas aeruginosa over-infection. J Virol Methods. 2021 Dec 10;300:114419. doi: 10.1016/j.jviromet.2021.114419. Epub 2021 Dec 10. PMID: 34896451; PMCID: PMC8660133.
Copy Download .nbib Format: NLM
SARS-Cov-2 pneumonia and concurrent myelodysplasia complicated by Pseudomonas aeruginosa over-infection.

Journal of virological methods

Pezzuto A, Tammaro A, Tonini G, Conforti G, Falangone F, Spuntarelli V, Teggi A, Pennica A.
PMID: 34896451
J Virol Methods. 2021 Dec 10;300:114419. doi: 10.1016/j.jviromet.2021.114419. Epub 2021 Dec 10.

The new virus called severe acute respiratory syndrome coronavirus 2 (SARSCov-2) causing Coronavirus disease 2019 (COVID-19) has spread quickly in several countries and it has become pandemic. Different types of clinical manifestations are attributed to this infection. Some mechanisms...

Cite
Pezzuto A, Tammaro A, Tonini G, et al. SARS-Cov-2 pneumonia and concurrent myelodysplasia complicated by Pseudomonas aeruginosa over-infection. J Virol Methods. 2021;300:114419doi: 10.1016/j.jviromet.2021.114419.
Pezzuto, A., Tammaro, A., Tonini, G., Conforti, G., Falangone, F., Spuntarelli, V., Teggi, A., & Pennica, A. (2021). SARS-Cov-2 pneumonia and concurrent myelodysplasia complicated by Pseudomonas aeruginosa over-infection. Journal of virological methods, 300114419. https://doi.org/10.1016/j.jviromet.2021.114419
Pezzuto, Aldo, et al. "SARS-Cov-2 pneumonia and concurrent myelodysplasia complicated by Pseudomonas aeruginosa over-infection." Journal of virological methods vol. 300 (2021): 114419. doi: https://doi.org/10.1016/j.jviromet.2021.114419
Pezzuto A, Tammaro A, Tonini G, Conforti G, Falangone F, Spuntarelli V, Teggi A, Pennica A. SARS-Cov-2 pneumonia and concurrent myelodysplasia complicated by Pseudomonas aeruginosa over-infection. J Virol Methods. 2021 Dec 10;300:114419. doi: 10.1016/j.jviromet.2021.114419. Epub 2021 Dec 10. PMID: 34896451; PMCID: PMC8660133.
Copy Download .nbib Format: NLM
SARS-Cov-2 pneumonia and concurrent myelodysplasia complicated by Pseudomonas aeruginosa over-infection.

Journal of virological methods

Pezzuto A, Tammaro A, Tonini G, Conforti G, Falangone F, Spuntarelli V, Teggi A, Pennica A.
PMID: 34896451
J Virol Methods. 2022 Feb;300:114419. doi: 10.1016/j.jviromet.2021.114419. Epub 2021 Dec 10.

The new virus called severe acute respiratory syndrome coronavirus 2 (SARSCov-2) causing Coronavirus disease 2019 (COVID-19) has spread quickly in several countries and it has become pandemic. Different types of clinical manifestations are attributed to this infection. Some mechanisms...

Cite
Pezzuto A, Tammaro A, Tonini G, et al. SARS-Cov-2 pneumonia and concurrent myelodysplasia complicated by Pseudomonas aeruginosa over-infection. J Virol Methods. 2021;300:114419doi: 10.1016/j.jviromet.2021.114419.
Pezzuto, A., Tammaro, A., Tonini, G., Conforti, G., Falangone, F., Spuntarelli, V., Teggi, A., & Pennica, A. (2022). SARS-Cov-2 pneumonia and concurrent myelodysplasia complicated by Pseudomonas aeruginosa over-infection. Journal of virological methods, 300114419. https://doi.org/10.1016/j.jviromet.2021.114419
Pezzuto, Aldo, et al. "SARS-Cov-2 pneumonia and concurrent myelodysplasia complicated by Pseudomonas aeruginosa over-infection." Journal of virological methods vol. 300 (2022): 114419. doi: https://doi.org/10.1016/j.jviromet.2021.114419
Pezzuto A, Tammaro A, Tonini G, Conforti G, Falangone F, Spuntarelli V, Teggi A, Pennica A. SARS-Cov-2 pneumonia and concurrent myelodysplasia complicated by Pseudomonas aeruginosa over-infection. J Virol Methods. 2022 Feb;300:114419. doi: 10.1016/j.jviromet.2021.114419. Epub 2021 Dec 10. PMID: 34896451; PMCID: PMC8660133.
Copy Download .nbib Format: NLM
Microglia and their LAG3 checkpoint underlie the antidepressant and neurogenesis-enhancing effects of electroconvulsive stimulation.

Molecular psychiatry

Rimmerman N, Verdiger H, Goldenberg H, Naggan L, Robinson E, Kozela E, Gelb S, Reshef R, Ryan KM, Ayoun L, Refaeli R, Ashkenazi E, Schottlender N, Ben Hemo-Cohen L, Pienica C, Aharonian M, Dinur E, Lazar K, McLoughlin DM, Zvi AB, Yirmiya R.
PMID: 34650207
Mol Psychiatry. 2021 Oct 14; doi: 10.1038/s41380-021-01338-0. Epub 2021 Oct 14.

Despite evidence implicating microglia in the etiology and pathophysiology of major depression, there is paucity of information regarding the contribution of microglia-dependent molecular pathways to antidepressant procedures. In this study, we investigated the role of microglia in a mouse...

Cite
Rimmerman N, Verdiger H, Goldenberg H, et al. Microglia and their LAG3 checkpoint underlie the antidepressant and neurogenesis-enhancing effects of electroconvulsive stimulation. Mol Psychiatry. 2021;doi: 10.1038/s41380-021-01338-0.
Rimmerman, N., Verdiger, H., Goldenberg, H., Naggan, L., Robinson, E., Kozela, E., Gelb, S., Reshef, R., Ryan, K. M., Ayoun, L., Refaeli, R., Ashkenazi, E., Schottlender, N., Ben Hemo-Cohen, L., Pienica, C., Aharonian, M., Dinur, E., Lazar, K., McLoughlin, D. M., Zvi, A. B., & Yirmiya, R. (2021). Microglia and their LAG3 checkpoint underlie the antidepressant and neurogenesis-enhancing effects of electroconvulsive stimulation. Molecular psychiatry, . https://doi.org/10.1038/s41380-021-01338-0
Rimmerman, Neta, et al. "Microglia and their LAG3 checkpoint underlie the antidepressant and neurogenesis-enhancing effects of electroconvulsive stimulation." Molecular psychiatry vol. (2021). doi: https://doi.org/10.1038/s41380-021-01338-0
Rimmerman N, Verdiger H, Goldenberg H, Naggan L, Robinson E, Kozela E, Gelb S, Reshef R, Ryan KM, Ayoun L, Refaeli R, Ashkenazi E, Schottlender N, Ben Hemo-Cohen L, Pienica C, Aharonian M, Dinur E, Lazar K, McLoughlin DM, Zvi AB, Yirmiya R. Microglia and their LAG3 checkpoint underlie the antidepressant and neurogenesis-enhancing effects of electroconvulsive stimulation. Mol Psychiatry. 2021 Oct 14; doi: 10.1038/s41380-021-01338-0. Epub 2021 Oct 14. PMID: 34650207.
Copy Download .nbib Format: NLM
Corrigendum to "Brain and cognitive functions in two groups of naïve HIV patients selected for a different plan of antiretroviral therapy: A qEEG study" [Clin. Neurophysiol. 127 (2016) 3455-3469].

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology

Babiloni C, Pennica A, Capotosto P, Onorati P, Muratori C, Ferracuti S, Roma P, Correr V, Piccinni E, Noce G, Del Percio C, Cordone S, Limatola C, Soricelli A, Di Campli F, Gianserra L, Ciullini L, Aceti A, Viscione M, Teti E, Sarmati L, Andreoni M.
PMID: 27899243
Clin Neurophysiol. 2017 Jan;128(1):288. doi: 10.1016/j.clinph.2016.11.003. Epub 2016 Nov 26.

No abstract available.

Cite
Babiloni C, Pennica A, Capotosto P, et al. Corrigendum to "Brain and cognitive functions in two groups of naïve HIV patients selected for a different plan of antiretroviral therapy: A qEEG study" [Clin. Neurophysiol. 127 (2016) 3455-3469]. Clin Neurophysiol. 2016;128(1):288doi: 10.1016/j.clinph.2016.11.003.
Babiloni, C., Pennica, A., Capotosto, P., Onorati, P., Muratori, C., Ferracuti, S., Roma, P., Correr, V., Piccinni, E., Noce, G., Del Percio, C., Cordone, S., Limatola, C., Soricelli, A., Di Campli, F., Gianserra, L., Ciullini, L., Aceti, A., Viscione, M., Teti, E., Sarmati, L., & Andreoni, M. (2017). Corrigendum to "Brain and cognitive functions in two groups of naïve HIV patients selected for a different plan of antiretroviral therapy: A qEEG study" [Clin. Neurophysiol. 127 (2016) 3455-3469]. Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology, 128(1), 288. https://doi.org/10.1016/j.clinph.2016.11.003
Babiloni, Claudio, et al. "Corrigendum to "Brain and cognitive functions in two groups of naïve HIV patients selected for a different plan of antiretroviral therapy: A qEEG study" [Clin. Neurophysiol. 127 (2016) 3455-3469]." Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology vol. 128,1 (2017): 288. doi: https://doi.org/10.1016/j.clinph.2016.11.003
Babiloni C, Pennica A, Capotosto P, Onorati P, Muratori C, Ferracuti S, Roma P, Correr V, Piccinni E, Noce G, Del Percio C, Cordone S, Limatola C, Soricelli A, Di Campli F, Gianserra L, Ciullini L, Aceti A, Viscione M, Teti E, Sarmati L, Andreoni M. Corrigendum to "Brain and cognitive functions in two groups of naïve HIV patients selected for a different plan of antiretroviral therapy: A qEEG study" [Clin. Neurophysiol. 127 (2016) 3455-3469]. Clin Neurophysiol. 2017 Jan;128(1):288. doi: 10.1016/j.clinph.2016.11.003. Epub 2016 Nov 26. PMID: 27899243.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 40 entries